Aerodynamic characteristics of a supersonic car
16 April, 2014An engineer working on the Bloodhound SSC (supersonic car) project has published a paper on the aerodynamic characteristics of travelling at 1000 mph (1609 km/h), increasing the current land speed record (LSR) by over 30%.
Australia and China form musculoskeletal research alliance
14 April, 2014A delegation of seven professors from Australian universities recently travelled to China to promote joint research in the musculoskeletal disciplines.
Fighting cancer with tobacco?
10 April, 2014Researchers from La Trobe University have found that the natural defence mechanisms of a tobacco plant could be harnessed to kill cancer cells in the human body.
Starpharma tech applied to AstraZeneca cancer drug
08 April, 2014Melbourne-based biotech company Starpharma has signed an expanded agreement with biopharma company AstraZeneca in the field of cancer medicine. The new agreement will see the application of Starpharma's dendrimer technology to a cancer drug from AstraZeneca's pipeline.
Botox may smooth out depression
03 April, 2014Researchers have conducted the largest randomised, double-blind, placebo-controlled study to date on the effect of OnabotulinumtoxinA (OBA, or Botox) on depression.
Computer models reveal the impact of continental collisions
25 March, 2014An international research project has uncovered new evidence about the formation of Earth. The study is the result of more than 10 years' work by scientists from Monash University, The University of Melbourne, the University of Southern California and the Geological Survey of Victoria.
Diagnostic device meets malaria field evaluation objective
25 March, 2014 | Supplied by: Fio CorporationFio Corporation's Deki Reader - a mobile in vitro diagnostic device - has demonstrated consistent interpretation of rapid diagnostic tests (RDTs) for multiple malaria strains in a field evaluation.
Patrys antibody shows promise in blood cancers
25 March, 2014Clinical-stage biotechnology company Patrys has released an update on the development program for its anticancer product PAT-LM1. The company's most recent laboratory experiments evaluated the efficacy of PAT-LM1 in blood cancers, including different types of leukaemias and lymphomas.
Statins slow the progression of advanced MS
24 March, 2014A study led by Imperial College London has found that statins may provide doctors with a way to slow the progression of multiple sclerosis (MS).
Millennium-old frozen moss comes back to life
21 March, 2014Researchers from the British Antarctic Survey and the University of Reading have demonstrated for the first time that after over 1500 years frozen in Antarctic ice, moss can come back to life and continue to grow.
First evidence of cosmic inflation found
21 March, 2014Researchers from the BICEP2 collaboration have announced the first direct evidence of cosmic inflation - the rapid expansion of the universe which immediately followed the Big Bang. Until now, the idea of this exponential expansion was just a theory.
Turning the spotlight on breast cancer cells
20 March, 2014Scientists are using the latest in nano-flare technology to detect breast cancer cells early on.
Drug testing with synthetic livers
19 March, 2014Scientists from clinical intelligence company Empiriko have developed chemosynthetic liver technology which could enable the testing of drug candidates without using animals.
Strings of galaxies found in empty space
11 March, 2014Australian astronomers have discovered short, delicate strings of faint galaxies in what were previously thought to be extremely empty parts of space.
Biomarkers reveal short-term risk of death
05 March, 2014Researchers from Finland and Estonia have discovered novel biological markers that indicate an individual's risk of dying from any disease in the near future.
